- 英文名称
- [5,8-Bis(carboxymethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oato]Gadolinium
- 分子式
- C16H26GdN5O8
- 分子量
- 573.66
- 中文别名
- Gadodiamide; gadodiamide; GDDTPA-BMA; Gadodiamide anhydrous; Gadolinium-DTPA-BMA; Gd DTPA-BMA; S-041; 84F6U3J2R6; DTXSID201019701; HSDB 7547; DV 7572; CHEBI:37333; Gadolinium, (5,8-bis((carboxy-kappaO)methyl)-11-(2-(methylamino)-2-(oxo-kappaO)ethyl)-3-(oxo-kappaO)-2,5,8,11-tetraazatridecan-13-oato(3-)-kappaN5,kappaN8,kappaN11,kappaO13)-; Gd-DTPA-BMA; RefChem:57217; Omniscan Unique Softpack; Gadolinium, aqua(5,8-bis(carboxymethyl)-11-(2-(methylamino)-2-oxoethyl)-3-oxo-2,5,8,11-tetraazatridecan-13-oato(3-))-, hydrate; Gd-DTPA bis-(methylamide); V08CA03; DTXCID001477620; 110-712-4; 2-(bis(2-(carboxymethyl-(2-methylimino-2-oxidoethyl)amino)ethyl)amino)acetate; gadolinium(3+); Omniscan; 2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxoethyl]amino]ethyl]amino]acetate; gadolinium(3+); gadolinium(III) 5,8-bis(carboxylatomethyl)-11-(2-(methylamino)-2-oxoethyl)-3-oxo-2,5,8,11-tetraazatridecan-13-oate; Omniscan (TN); Gadodiamide (USP/INN); GADODIAMIDE [MI]; gadolinium 5,8-bis(carboxylatomethyl)-11-[2-(methylamino)-2-oxoethyl]-3-oxo-2,5,8,11-tetraazatridecan-13-oate; GADODIAMIDE [INN]; Gadodiamide, Gd-Dtpa-Bma; GADODIAMIDE [HSDB]; GADODIAMIDE [USAN]; GADODIAMIDE [VANDF]; GADODIAMIDE [MART.]; SCHEMBL73031; GADODIAMIDE [USP-RS]; GADODIAMIDE [WHO-DD]; GADODIAMIDE [ORANGE BOOK]; MOLI001033; GADODIAMIDE [USP MONOGRAPH]; AC-925; EBC-27339; AKOS015900642; DB-042031; NS00078751; D04284; F02-0056; [N,N-Bis[2-[(carboxymethyl)[(methylcarbamoyl)methyl]amino]ethyl]glycinato(3-)]gadolinium; (5,8-BIS(CARBOXYMETHYL)-11-(2-(METHYLAMINO)-2-OXOETHYL)-3-OXO-2,5,8,11-TETRAAZATRIDECAN-13-OATO(3-))GADOLINIUM; gadolinium(III) 5,8-bis(carboxylatomethyl)-2-[2-(methylamino)-2-oxoethyl]-10-oxo-2,5,8,11-tetraazadodecane-1-carboxylate
- 用途
- 用于静脉注射MRI,以可视化脑(颅内病变)、脊柱及相关组织中血管异常或血脑屏障异常的病变;典型造影剂为钆基化合物,具有比软组织更高的线性衰减系数;适用于中枢神经(脑及脊髓)、腹、胸、盆腔及四肢等的磁共振成像,所需剂量必须一次静注,可用生理盐水冲洗静注导管以确保注射完全。